![]() |
e-ESC online discussion of Her2+ MBC management
Requires registration but these are usually very informative sessions--bird
http://www.e-eso.net/egrandround.do?...ll=listafuturi Next live session Current: Management of HER-2 positive MBC? an update CME accredited e-grandround GR186 - 08 March 2012 - 18:15-19:00 CET Expert: Javier Cortes, Vall d'Hebron Institute of Oncology, Barcelona, Spain Discussant: Fatima Cardoso, Champalimaud Cancer Center, Lisbon, Portugal Topics: Breast cancer View details |
Re: e-ESC online discussion of Her2+ MBC management
Thanks, 1rarebird.
|
Re: e-ESC online discussion of Her2+ MBC management
This turned out for me to be a very informative summation of the data which is currently used to plan treatment strategies for Her2+ MBC, at least in the clinical trial setting. The discussions about Petuzamab + Herceptin and TDM-1 were the most encouraging to me. I will admit that most of that information has been discussed on our forum in recent past, but it is always good to get it summarized by practicing oncologists. I would recommend that anyone not able to tune in to the live webcast today might check back with the ESO website in the next few days to see when the video of the presentation is up for viewing. It will be an hour well spent, IMHO.---bird
|
| All times are GMT -7. The time now is 01:40 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021